(Q36249019)

13 August 2017

0 references

1 reference

title

Reduced risk of back pain following teriparatide treatment: a meta-analysis (English)

1 reference

13 August 2017

1 reference

4

Jean-Yves Reginster

1 reference

13 August 2017

1

Michael C Nevitt

1 reference

13 August 2017

Peiqi Chen

2

1 reference

13 August 2017

Robin K Dore

3

1 reference

13 August 2017

Douglas P Kiel

5

1 reference

13 August 2017

Jose R Zanchetta

6

1 reference

13 August 2017

Emmett V Glass

7

1 reference

13 August 2017

John H Krege

8

1 reference

13 August 2017

language of work or name

English

0 references

publication date

2 September 2005

1 reference

Osteoporosis International

13 August 2017

published in

1 reference

13 August 2017

volume

17

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

273-280

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-005-2013-2

13 August 2017

exact match

0 references

cites work

The association of radiographically detected vertebral fractures with back pain and function: a prospective study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-005-2013-2

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

21 January 2018

1 reference

12 December 2020

The clinical impact of vertebral fractures: quality of life in women with osteoporosis

1 reference

12 December 2020

Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss. European Vertebral Osteoporosis Study Group

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis

1 reference

12 December 2020

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

1 reference

12 December 2020

Initial outcome and efficacy of "kyphoplasty" in the treatment of painful osteoporotic vertebral compression fractures

1 reference

12 December 2020

Hospital care of osteoporosis-related vertebral fractures

1 reference

12 December 2020

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989

1 reference

12 December 2020

Health Impact Associated with Vertebral Deformities: Results from the European Vertebral Osteoporosis Study (EVOS)

1 reference

12 December 2020

Vertebral deformity, back symptoms, and functional limitations among older women: The Framingham Study

1 reference

12 December 2020

Association of osteoporotic vertebral compression fractures with impaired functional status

1 reference

12 December 2020

Prevalence and incidence of vertebral deformities

1 reference

12 December 2020

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

1 reference

12 December 2020

Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Is hormone replacement therapy a risk factor for low back pain among postmenopausal women?

1 reference

12 December 2020

Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass

1 reference

12 December 2020

The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study

1 reference

12 December 2020

Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures

1 reference

12 December 2020

Back Problems Among Postmenopausal Women Taking Estrogen Replacement Therapy

1 reference

12 December 2020

Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).

1 reference

12 December 2020

Management of patients with vertebral compression fractures.

1 reference

12 December 2020

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

The hospital cost of vertebral fractures in the EU: estimates using national datasets

1 reference

12 December 2020

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

12 December 2020

1 reference

12 December 2020

Osteoporosis--the disease of the 21st century?

1 reference

12 December 2020

Vertebral compression fractures: manage aggressively to prevent sequelae

1 reference

12 December 2020

The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis

1 reference

12 December 2020

The worldwide problem of osteoporosis: insights afforded by epidemiology

1 reference

12 December 2020

Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels

1 reference

12 December 2020

Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

10.1007/S00198-005-2013-2

Identifiers

DOI

1 reference

13 August 2017

1 reference